New Developments in Pediatric Antifungal Pharmacology

被引：5
作者：
Groll, Andreas H. [1 ,2 ]
Roilides, Emmanuel [3 ,4 ]
Walsh, Thomas J. [5 ,6 ]
机构：
[1] Univ Childrens Hosp, Ctr Bone Marrow Transplantat, Infect Dis Res Program, Albert Schweitzer Campus 1, D-48129 Munster, Germany
[2] Univ Childrens Hosp, Dept Pediat Hematol Oncol, Albert Schweitzer Campus 1, D-48129 Munster, Germany
[3] Aristotle Univ Thessaloniki, Fac Hlth Sci, Sch Med, Dept Pediat 3,Infect Dis Unit, Thessaloniki, Greece
[4] Hippokrateion Hosp, Thessaloniki, Greece
[5] Ctr Innovat Therapeut & Diagnost, Richmond, VA USA
[6] Univ Maryland, Sch Med, Baltimore, MD 21201 USA
来源：
PEDIATRIC INFECTIOUS DISEASE JOURNAL | 2022年 / 41卷 / 12期
关键词：
mycoses; pharmacology; children; antifungal agents; posaconazole; isavuconazole; anidulafungin; investigational agents; PHARMACOKINETICS; ANIDULAFUNGIN; SAFETY;
D O I：
10.1097/INF.0000000000003659
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：E530 / E533
页数：4
相关论文
共 12 条
  • [1] Safety, Tolerability, and Population Pharmacokinetics of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients
    Arrieta, Antonio C.
    Neely, Michael
    Day, J. Christopher
    Rheingold, Susan R.
    Sue, Paul K.
    Muller, William J.
    Danziger-Isakov, Lara A.
    Chu, Julie
    Yildirim, Inci
    McComsey, Grace A.
    Frangoul, Haydar A.
    Chen, Tempe K.
    Statler, Victoria A.
    Steinbach, William J.
    Yin, Dwight E.
    Hamed, Kamal
    Jones, Mark E.
    Lademacher, Christopher
    Desai, Amit
    Micklus, Kelley
    Phillips, Desiree Leiva
    Kovanda, Laura L.
    Walsh, Thomas J.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (08)
  • [2] A non-randomized trial to assess the safety, tolerability, and pharmacokinetics of posaconazole oral suspension in immunocompromised children with neutropenia
    Arrieta, Antonio C.
    Sung, Lillian
    Bradley, John S.
    Zwaan, C. Michel
    Gates, Davis
    Waskin, Hetty
    Carmelitano, Patricia
    Gro, Andreas H.
    Lehrnbecher, Thomas
    Mangin, Eric
    Joshi, Amita
    Kartsonis, Nicholas A.
    Walsh, Thomas J.
    Paschke, Amanda
    [J]. PLOS ONE, 2019, 14 (03):
  • [3] Safety and pharmacokinetics of intravenous anidulafungin in children with neutropenia at high risk for invasive fungal infections
    Benjamin, DK
    Driscoll, T
    Seibel, NL
    Gonzalez, CE
    Roden, MM
    Kilaru, R
    Clark, K
    Dowell, JA
    Schranz, J
    Walsh, TJ
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (02) : 632 - 638
  • [4] Safety and Pharmacokinetics of Multiple-Dose Anidulafungin in Infants and Neonates
    Cohen-Wolkowiez, M.
    Benjamin, D. K., Jr.
    Piper, L.
    Cheifetz, I. M.
    Moran, C.
    Liu, P.
    Aram, J.
    Kashuba, A. D. M.
    Capparelli, E.
    Walsh, T. J.
    Hope, W. W.
    Smith, P. B.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 (05) : 702 - 707
  • [5] Administration and Dosing of Systemic Antifungal Agents in Pediatric Patients
    Downes, Kevin J.
    Fisher, Brian T.
    Zane, Nicole R.
    [J]. PEDIATRIC DRUGS, 2020, 22 (02) : 165 - 188
  • [6] Pharmacokinetics and safety of posaconazole intravenous solution and powder for oral suspension in children with neutropenia: an open-label, sequential dose-escalation trial
    Groll, Andreas H.
    Abdel-Azim, Hisham
    Lehrnbecher, Thomas
    Steinbach, William J.
    Paschke, Amanda
    Mangin, Eric
    Winchell, Gregory A.
    Waskin, Hetty
    Bruno, Christopher J.
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 56 (03)
  • [7] The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin
    Hoenigl, Martin
    Sprute, Rosanne
    Egger, Matthias
    Arastehfar, Amir
    Cornely, Oliver A.
    Krause, Robert
    Lass-Florl, Cornelia
    Prattes, Juergen
    Spec, Andrej
    Thompson, George R., III
    Wiederhold, Nathan
    Jenks, Jeffrey D.
    [J]. DRUGS, 2021, 81 (15) : 1703 - 1729
  • [8] Jacobs Samantha E, 2021, F1000Res, V10, P507, DOI 10.12688/f1000research.28327.1
  • [9] Epidemiology of Invasive Fungal Disease in Children
    Pana, Zoi Dorothea
    Roilides, Emmanuel
    Warris, Adilia
    Groll, Andreas H.
    Zaoutis, Theoklis
    [J]. JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2017, 6 : S3 - S11
  • [10] Safety, Efficacy and Pharmacokinetics of Anidulafungin in Patients 1 Month to <2 Years of Age With Invasive Candidiasis, Including Candidemia
    Roilides, Emmanuel
    Carlesse, Fabianne
    Tawadrous, Margaret
    Leister-Tebbe, Heidi
    Conte, Umberto
    Raber, Susan
    Swanson, Robert
    Yan, Jean L.
    Aram, Jalal A.
    Queiroz-Telles, Flavio
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2020, 39 (04) : 305 - 309
12